Did you find what you are/were looking for
?
If not, read below and browse through other relevant pages for similar market research
reports OR get in touch with us through the form/contact info in your right navigation
panel and we’ll share relevant market report titles for you to explore.
- Stem Cell Research Products - Opportunities, Tools, and Technologies
OverviewStaying ahead of a hungry and fast moving pack of competitors requires the very best market insights.So let’s get straight to the point.We’re offering you access to a sophisticated market i...
- Strategic Development of Neural Stem & Progenitor Cell Products
Overview: Neurogenesis is the process by which neurons are created. This process is most active during pre-natal development when neurogenesis is responsible for populating the growing brain. Neural stem cells (NSCs) are the self-renewing, m...
- Stem Cells: Worldwide Markets for Transplantation, Cord Blood Banking and Drug Development
Report SummaryThere is great interest in stem cells because they have potential to replace defective or damaged cells resulting from a variety of disorders and injuries, leading to a range of new regenerative therapies. Ste...
- Stem Cell Research Market to 2017 - Strong Pipeline, High Unmet Needs in Chronic Diseases and Favorable Government Policies to Boost Stem Cell R&D
Report SummaryGBI Research, the leading business intelligence provider, has released its latest research Stem Cell Research Market to 2017 - Strong Pipe...
- Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
GBI Research, the leading business intelligence provider, has released its latest research ”. It is an essential source o...
- Stakeholder Opinions: Therapeutic Vaccines - A far-off promise of greatness
IntroductionThe development of therapeutic vaccines has expanded beyond cancer indications and is attracting increasing interest from Pharma and Biotech, driven by potential advantages such as improved specificity, long-las...
- Stakeholder Opinions: Gene Therapy - Gene therapy to deliver after 20 years of clinical development
IntroductionGene therapy looks to be coming of age, with seven projects in Phase III clinical development and one project currently under regulatory review. A shift in development from pure gene replacement to using gene th...
- Stakeholder Opinions: Tuberculosis - Development pipeline shows signs of life
IntroductionTuberculosis is a major cause of illness and death worldwide, but despite 14.4 million prevalent cases, 9.2 million new cases and 1.7 million deaths in 2006, the small and rapidly declining burden of disease in the seven ...